Archimedes
Open Access
- 1 November 2003
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (11) , 3093-3101
- https://doi.org/10.2337/diacare.26.11.3093
Abstract
OBJECTIVE—To build a mathematical model of the anatomy, pathophysiology, tests, treatments, and outcomes pertaining to diabetes that could be applied to a wide variety of clinical and administrative problems and that could be validated. RESEARCH DESIGN AND METHODS—We used an object-oriented approach, differential equations, and a construct we call “features.” The level of detail and realism was determined by what clinicians considered important, by the need to distinguish clinically relevant variables, and by the level of detail used in the conduct of clinical trials. RESULTS—The model includes the pertinent organ systems, more than 50 continuously interacting biological variables, and the major symptoms, tests, treatments, and outcomes. The level of detail corresponds to that found in general medical textbooks, patient charts, clinical practice guidelines, and designs of clinical trials. The model is continuous in time and represents biological variables continuously. As demonstrated in a companion article, the equations can simulate a variety of clinical trials and reproduce their results with good accuracy. CONCLUSIONS—It is possible to build a mathematical model that replicates the pathophysiology of diabetes at a high level of biological and clinical detail and that can be tested by simulating clinical trials.This publication has 34 references indexed in Scilit:
- Archimedes: a new model for simulating health care systems—the mathematical formulationJournal of Biomedical Informatics, 2002
- Recent Developments in the Pharmacological Reduction of Blood Glucose in Patients With Type 2 DiabetesClinical Diabetes, 2001
- The Importance of -Cell Failure in the Development and Progression of Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2001
- The Cost-effectiveness of Screening for Type 2 DiabetesJAMA, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesDiabetes, 1997
- Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987